Target intelligence / Profile preview

RNA, U6atac small nuclear 23, pseudogene (RNU6ATAC23P)

Target
RNU6ATAC23P
Molecular classification
Other (specifically: snRNA pseudogene)
01

Overview

RNU6ATAC23P is a pseudogene of a small nuclear RNA (snRNA) belonging to the U6atac family. Small nuclear RNAs are essential noncoding RNAs that normally function within the spliceosome, a complex responsible for removing introns from pre-mRNA. However, as a pseudogene, RNU6ATAC23P is typically not transcribed or does not give rise to a functional snRNA molecule and lacks known biological, clinical, or pharmacological relevance. Pseudogenes such as this are often genomic "relics" rather than active participants in cellular physiology. Additional Context: - U6atac snRNA: In general, the canonical U6atac snRNA is involved in the minor (U12-type) spliceosome, which processes a rare class of introns in eukaryotic genes. However, pseudogenes like RNU6ATAC23P do not contribute to this function. - Pseudogenes: Pseudogenes are gene remnants that have lost their original function through mutation. While some pseudogenes are occasionally transcribed and implicated in regulatory networks, most are not functionally relevant, especially as drug targets. - No evidence for targeting: There are no reports of drugs, diagnostic, or therapeutic applications involving this pseudogene. If you are seeking a functionally relevant, druggable target, the canonical U6atac snRNA may be of interest primarily for RNA biology, but not the RNU6ATAC23P pseudogene itself.

Other names
RNU6ATAC23PU6atac-23P
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene, this sequence does not produce a functional RNA or protein)
04

Disease associations

Other (no established disease role; pseudogenes occasionally have regulatory effects but none are established for RNU6ATAC23P)

Beyond the preview

Go deeper on RNA, U6atac small nuclear 23, pseudogene (RNU6ATAC23P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6atac small nuclear 23, pseudogene (RNU6ATAC23P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call